(Q68630612)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

title

Effect of chronic ketanserin treatment on serotonin-induced platelet aggregation in patients with Raynaud's phenomenon (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference

B Marasini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

M L Biondi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

R Mollica

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

26 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

page(s)

289-290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00315113

26 September 2019

exact match

0 references

cites work

Platelet hypersensitivity to serotonin after prolonged ketanserin intake?

1 reference

12 December 2020

Pharmacokinetics and Pharmacodynamics of the 5-HT2 Receptor Antagonist Ketanserin in Man

1 reference

12 December 2020

Hypersensitivity of scleroderma cutaneous vascular smooth muscle to 5-hydroxytryptamine

1 reference

12 December 2020

Abnormal platelet aggregation in patients with Raynaud's phenomenon

1 reference

12 December 2020

Ketanserin treatment and serotonin in patients with primary and secondary Raynaud's phenomenon

1 reference

12 December 2020

Effect of ketanserin on the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases

1 reference

12 December 2020

Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study

1 reference

12 December 2020

Continuous inhibition of platelet S2-serotonergic receptors during chronic administration of ketanserin in humans

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00315113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2257869%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference